Alchemia Limited (ASX:ACL) Announces Half-year Results for Period Ended 31 December 2013
Alchemia Limited (ASX:ACL) a drug discovery and development company, is pleased to announce its half year results for the six months ended 31 December 2013.
Companies in the News
Biotech
Rhinomed Limited (ASX:RNO) Releases Radical New Respiratory Sporting Technology
Medical technology company Rhinomed, (ASX:RNO) has today released its inaugural product in the Australian market, the radical new respiratory sporting technology, the Turbine(TM).
SomnoMed (ASX:SOM) Expands in Korea with SomnoDent(R) for Treatment of Obstructive Sleep Apnea
SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today the expansion of its business in the Republic of Korea, following the registration by the Korean FDA of SomnoDent(R) as an accepted medical device for the treatment of obstructive sleep apnea.
Life Sciences Reaches New Heights at Sydney Sky Tower on October 21, 2013
Life Sciences is the hot topic for many investors as they seek to secure alternatives to conventional resources and energy investments. 4 Companies in the Life Sciences sector will be presenting their company and investment opportunity to sophisticated investors at the Sydney Sky Tower on Monday, October 21st.
Biotron Limited (ASX:BIT) Recently Announced Key Milestone in Clinical Trial for Hepatitis and HIV
Biotron Limited (ASX:BIT) (OTCMKTS:BITRF) was pleased to recently announce that it has achieved another key milestone, with the final patient enrolled in an important Phase 2 clinical trial of BIT225 in patients co-infected with Hepatitis C virus (HCV) and HIV.
Microskin PLC (GXG:MSKN) Granted Approval from Saudi FDA
Microskin PLC (GXG:MSKN), a revolutionary second skin technology company, has received approval from the Saudi FDA to import its product allowing operations to commence immediately in Riyadh, Saudi Arabia.
Medistem (OTCMKTS:MEDS), Enters Collaboration with Boston Academic Teaching Hospital to Expand Preclinical Data in Type 1 Diabetes
Medistem, Inc. (OTCMKTS:MEDS), announced today it has entered into collaboration with Reza Abdi, M.D., Transplant Nephrologist at Brigham and Women's Hospital and Assistant Professor of Medicine, Harvard Medical School.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
Social Media
